Research programme: substance P derivative - ImmuneRegen

Drug Profile

Research programme: substance P derivative - ImmuneRegen

Alternative Names: Homspera; Radilex; Sar9, Met (O2)11-Substance P; Viprovex

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator ImmuneRegen BioSciences
  • Developer GenPhar; Hyperion Biotechnology; ImmuneRegen BioSciences
  • Class Adjuvants; Antineoplastics; Antitoxins; Antivirals; Peptides
  • Mechanism of Action Immunostimulants; Neurokinin 1 receptor agonists; Stem cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • No development reported Anthrax; Influenza virus infections; Lung disorders; Malignant melanoma; Melioidosis; Pulmonary fibrosis; Radiation injuries; Wounds
  • Discontinued Acute asthma; Adult respiratory distress syndrome; Male pattern baldness

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Wounds in USA (Intralesional)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Melioidosis in Singapore (Parenteral)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Pulmonary-fibrosis in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top